Table 2 Demographic and clinical details for patients with apparent treatment-resistant hypertension in feasibility study (n = 210)
From: Prognosis of patients with apparent treatment-resistant hypertension—a feasibility study
Demographic | (Mean if applicable) | Standard deviation (from mean) |
|---|---|---|
Age (years) | 73.7 YOA | 11.2 |
Sex | 56% male | |
Eligible for Primary Care Reimbursement Scheme (marker of household income) | 80% (n = 167) | |
Clinical details | ||
Diabetes | 31% (n = 65) | |
CKD | 41% (n = 87) | |
Cardiac failure | 15% (n = 31) | |
Manual BP | 138/75 mmHg | 19/12 mmHg |
Recent ABPM BP (where available within 23 months median follow-up period) | 134/76 mmHg (n = 112) | 16/10 mmHg |
Medications | ||
No. of anti-hypertensive drugs used | 3.7 | 1.06 |
4 or more anti-hypertensive drugs | 51% | |
Subdivisions | ||
True TRH | 26% (n = 65) | |
Pseudo-resistant THR | 74% (n = 140) | |